Adriaan Meyer, Heather Hendrickse, Glenda Mary Davison
{"title":"Neocyte-enriched blood does not provide a survival advantage for red cells when compared to conventional filtered blood.","authors":"Adriaan Meyer, Heather Hendrickse, Glenda Mary Davison","doi":"10.1111/vox.70085","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Red blood cell (RBC) concentrates are stored at 1-6°C for up to 42 days, but storage lesions can lead to wastage. Pooled neocytes may extend RBC shelf-life, benefiting patients who require frequent transfusions. This study aimed to improve the longevity of stored RBCs by isolating neocytes and comparing the rate of haemolysis, biochemical changes and viability with filtered blood.</p><p><strong>Materials and methods: </strong>Thirty filtered units were processed. Neocytes were extracted and enriched with saline-adenine- glucose-mannitol. Both filtered and neocyte-enriched units were stored for 42 days. Samples were analysed every 14 days for RBC count, mean cell volume (MCV), mean cell haemoglobin concentration (MCHC), haemoglobin, sodium and supernatant haemolysis.</p><p><strong>Results: </strong>There was no significant difference in red cell count between filtered and neocyte-enriched units (p = 0.27). Both types showed increased mean corpuscular volume and decreased MCHC over the 42 days, with no significant differences observed (p ≥ 0.05). Sodium levels in the supernatant decreased while percentage supernatant haemolysis increased steadily in both units, albeit without significant differences (p ≥ 0.05). The haemoglobin remained stable for both unit types.</p><p><strong>Conclusion: </strong>Overall, neocyte-enriched blood did not demonstrate any longevity advantage compared to pre-stored leucocyte-reduced RBCs using the conventional manual collection method. These findings align with previous studies using various neocyte collection methods. Feasibility was highlighted as the main challenge, as many of these methods have proven too expensive and laborious.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70085","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Red blood cell (RBC) concentrates are stored at 1-6°C for up to 42 days, but storage lesions can lead to wastage. Pooled neocytes may extend RBC shelf-life, benefiting patients who require frequent transfusions. This study aimed to improve the longevity of stored RBCs by isolating neocytes and comparing the rate of haemolysis, biochemical changes and viability with filtered blood.
Materials and methods: Thirty filtered units were processed. Neocytes were extracted and enriched with saline-adenine- glucose-mannitol. Both filtered and neocyte-enriched units were stored for 42 days. Samples were analysed every 14 days for RBC count, mean cell volume (MCV), mean cell haemoglobin concentration (MCHC), haemoglobin, sodium and supernatant haemolysis.
Results: There was no significant difference in red cell count between filtered and neocyte-enriched units (p = 0.27). Both types showed increased mean corpuscular volume and decreased MCHC over the 42 days, with no significant differences observed (p ≥ 0.05). Sodium levels in the supernatant decreased while percentage supernatant haemolysis increased steadily in both units, albeit without significant differences (p ≥ 0.05). The haemoglobin remained stable for both unit types.
Conclusion: Overall, neocyte-enriched blood did not demonstrate any longevity advantage compared to pre-stored leucocyte-reduced RBCs using the conventional manual collection method. These findings align with previous studies using various neocyte collection methods. Feasibility was highlighted as the main challenge, as many of these methods have proven too expensive and laborious.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.